News
Older adults tolerate neoadjuvant chemoradiation for oesophageal cancer well, with survival outcomes comparable to younger ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback